CELLULAR BIOMEDICINE GROUP I - COM NEW (CBMG)

CUSIP: 15117P102

Q2 2015 13F Holders as of 30 Jun 2015

Type / Class
Equity / COM NEW
Total 13F shares
806,551
Share change
+449,092
Total reported value
$30,257,004
Price per share
$37.51
Number of holders
45
Value change
+$18,174,078
Number of buys
36
Number of sells
13

Quarterly Holders Quick Answers

What is CUSIP 15117P102?
CUSIP 15117P102 identifies CBMG - CELLULAR BIOMEDICINE GROUP I - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CELLULAR BIOMEDICINE GROUP I - COM NEW (CBMG) as of Q2 2015

As of 30 Jun 2015, CELLULAR BIOMEDICINE GROUP I - COM NEW (CBMG) was held by 45 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 806,551 shares. The largest 10 holders included BlackRock Fund Advisors, BlackRock Institutional Trust Company, N.A., STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, Bank of New York Mellon Corp, BlackRock Investment Management, LLC, NORTHERN TRUST CORP, A.R.T. Advisors, LLC, and TIAA CREF INVESTMENT MANAGEMENT LLC. This page lists 45 institutional shareholders reporting positions in this security for the Q2 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.